MINDRANK AI
MindRank (www.mindrank.ai) is an AI-driven biotech company with focus on “Undruggable” targets. The company started operations in 2021 and now consists of 35 scientists with R&D center in China and UK. The company is led by academicians of the British Royal Society, former R&D scientists from top pharma companies and the global AI competition winners. The team has successful experience in drug R&D and have a large number top publications including Nature Biomedical Engineering, Nature Mach... ine Intelligence, Patterns (Cell Press) etc. By leveraging its proprietary AI driven drug discovery platform, MindRank has delivered a small molecule Preclinical Candidate (allosteric inhibitor) to a listed biotechnology company in Sept 2021. In Jan 2022, MindRank begins IND-enabling studies of its proprietary AI-designed drug (Class B GPCR), 8 months after program initiation. Both of the small molecule drugs are expected to enter clinical phase in 2022.
MINDRANK AI
Social Links:
Industry:
Artificial Intelligence Biotechnology Health Care Pharmaceutical
Founded:
2020-12-23
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.mindrank.ai
Total Employee:
11+
Status:
Active
Contact:
+86 13761764536
Email Addresses:
[email protected]
Total Funding:
26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Euro Amazon Google Apps For Business
Similar Organizations
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Navina
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits for better diagnoses and care.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
Investors List
Green Pine Capital Partners
Green Pine Capital Partners investment in Series A - MindRank AI
Huagai Capital
Huagai Capital investment in Series A - MindRank AI
Sherpa Venture Capital
Sherpa Venture Capital investment in Series A - MindRank AI
Sherpa Venture Capital
Sherpa Venture Capital investment in Seed Round - MindRank AI
Official Site Inspections
http://www.mindrank.ai
- Host name: ec2-18-163-59-105.ap-east-1.compute.amazonaws.com
- IP address: 18.163.59.105
- Location: Hong Kong
- Latitude: 22.2909
- Longitude: 114.15
- Timezone: Asia/Hong_Kong
